ISSN: 1936-2625
官网: http://www.ijcem.com/contents.html
出版商: e-century
| Title | Scholar cited | Year | Review Cycle | Accept Cycle |
|---|---|---|---|---|
|
Effects of resveratrol on the Nrf2 and HO-1 expression in diabetic vascular endothelial cells. Int J Clin Exp Med 2017;10(1):684-691. (Abstract IJCEM0019905, Full text
|
- | 2017 | - | - |
|
miR-181a promotes apoptosis in contusion spinal cord injury rats through targeting Bcl-2. Int J Clin Exp Med 2017;10(2):2773-2781. (Abstract IJCEM0038508, Full text
|
- | 2017 | - | - |
|
Effects of valproic acid on the differentiation of endogenous neural stem cells of the hippocampus in rats. Int J Clin Exp Med 2017;10(3):4732-4739. (Abstract IJCEM0045349, Full text
|
- | 2017 | - | - |
|
Dexmedetomidine reduces hypoxia/reoxygenation injury by regulating mitochondrial fission in rat hippocampal neurons. Int J Clin Exp Med 2017;10(4):6861-6868. (Abstract IJCEM0051456, Full text
|
- | 2017 | - | - |
|
Combination treatment with breviscapine and netrin-1 suppresses permanent focal cerebral ischemic injury by activating PGE2 receptor. Int J Clin Exp Med 2017;10(6):8907-8916. (Abstract IJCEM0020737, Full text
|
- | 2017 | - | - |
|
Management of retroperitoneal teratoma in infants younger than one-year-old. Int J Clin Exp Med 2018;11(2):1362-1366. (Abstract IJCEM0049294, Full text
|
- | 2018 | - | - |
|
Toll like receptor 2 induces kidney inflammation via MyD88/NF-κB signaling pathway. Int J Clin Exp Med 2018;11(4):3494-3503. (Abstract IJCEM0062865, Full text
|
- | 2018 | - | - |
|
Zinc transporter 1 (ZnT1) is overexpressed in bladder cancer and promotes the proliferation and invasion of bladder cancer BIU87 cells. Int J Clin Exp Med 2018;11(5):5323-5331. (Abstract IJCEM0066249, Full text
|
- | 2018 | - | - |
|
Feasibility and outcomes of colonoscopy with combined carbon dioxide insufflation and water infusion for resection of colonic polyps. Int J Clin Exp Med 2018;11(7):7408-7414. (Abstract IJCEM0069233, Full text
|
- | 2018 | - | - |
|
Colon cancer stem cells from HT29 cell line resist to arctigenin via suppressing ROS production. Int J Clin Exp Med 2017;10(2):2782-2790. (Abstract IJCEM0039952, Full text
|
- | 2017 | - | - |